Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 1128 for “"tuberculosis"”.

  1. Mycobacterium tuberculosis ClpC1: A potential target for tuberculosis drug discovery

    … displaying potent activity against Mycobacterium tuberculosis (MIC50=0.05-0.1N<M). This compound is active against multidrug resistant clinical isolates, implying a new target. A preliminary study to identify the putative target of this compound was carried out to elucidate its mechanism of …

    nus Repository record for Mycobacterium tuberculosis ClpC1: A potential target for tuberculosis drug discovery (opens in a new tab)

  2. Mycobacterium tuberculosis metallomics

    Tuberculosis (TB) remains a major global health challenge, compounded by the rise of drug-resistant Mycobacterium tuberculosis (Mtb) strains, which necessitate the development of novel therapies or improvement of existing ones. Nanotechnology has gained prominence in the biomedical field, yet its …

    stellenbosch Repository record for Mycobacterium tuberculosis metallomics (opens in a new tab)

  3. Tuberculosis: The Opportunistic Disease

    Tuberculosis is an ancient disease caused by one of the most virulent and fatal biological agents; Mycobacterium tuberculosis (M. tuberculosis). Active pulmonary tuberculosis (TB) infection, which was nearly eradicated a generation ago, started to reemerge in a concerning manner in the late 1980's …

    unr Repository record for Tuberculosis: The Opportunistic Disease (opens in a new tab)

  4. Studies of childhood tuberculosis

    Includes abstract. Includes bibliographical references (leaves 200-218).

    cape-town Repository record for Studies of childhood tuberculosis (opens in a new tab)

  5. Reactivation of persistant tuberculosis

    Exposure to Mycobacterium tuberculosis results in clinical tuberculosis only in a small percentage of immunocompetent individuals. In most instances mycobacteria are controlled by the host immune system and survive in a dormant state within granuloma. lmmunosuppression, however, may result in …

    cape-town Repository record for Reactivation of persistant tuberculosis (opens in a new tab)

  6. Addressing challenges in the treatment of tuberculosis and tuberculosis meningitis: a pharmacometric approach

    Tuberculosis (TB) is the primary cause of death from a single infectious agent worldwide. During the coronavirus disease (COVID-19) pandemic, TB briefly fell to second place, but it has now regained its position as the top infectious killer. It is caused by Mycobacterium tuberculosis and mainly …

    cape-town Repository record for Addressing challenges in the treatment of tuberculosis and tuberculosis meningitis: a pharmacometric approach (opens in a new tab)

  7. Tenosinovitis infecciosa por Mycobacterium Tuberculosis

    … de manifestación extrapulmonar del Mycobacterium tuberculosis, etiología que por su comportamiento clínico y paraclínico puede confundir al examinador retardando su proceso diagnóstico Este artículo presenta el caso de un paciente masculino de 63 años, diestro, cesante, sin antecedentes relevantes …

    rosario Repository record for Tenosinovitis infecciosa por Mycobacterium Tuberculosis (opens in a new tab)

  8. Vertebral tuberculosis : a clinical study

    (1) Tuberculosis of the spinal column is local evidence of pre- existing general infection. The influence of this conception on treatment is emphasised.

    edinburgh Repository record for Vertebral tuberculosis : a clinical study (opens in a new tab)

  9. Modelling the transmission of tuberculosis

    Airborne infectious diseases, such as tuberculosis (TB), are spread by airborne infectious particles (viable particles with potential for TB infection) in exhaled air from infectious individuals in enclosed spaces. Exhaled air is the carrier of airborne infectious particles and carbon dioxide is …

    cape-town Repository record for Modelling the transmission of tuberculosis (opens in a new tab)

  10. Gaucher Disease Protects Against Tuberculosis

    … in particular conferring protection against tuberculosis. Here, using a zebrafish Gaucher disease model, I find that the mutation GBA1 N370S, predominant among Ashkenazi Jews, increases resistance to tuberculosis through the microbicidal activity of glucosylsphingosine in macrophage …

    cambridge Repository record for Gaucher Disease Protects Against Tuberculosis (opens in a new tab)

  11. Immunological analysis of pericardial tuberculosis

    Pericardial tuberculosis (TB) offers a relevant human model to study TB at the site of disease and to determine the effect of HIV-1 infection. 96 Patients with pericardial TB were recruited into this study, 68 of whom were HIV-1 infected. Where clinically indicated, pericardiocentesis was performed …

    cape-town Repository record for Immunological analysis of pericardial tuberculosis (opens in a new tab)

  12. Outcome of Tuberculosis treatment in sputum positive patients after eight months of anti-tuberculosis therapy

    … of the study was to find out the outcome of tuberculosis treatment in Sputum Positive Patients after eight months anti-tuberculosis treatment. Observation and literature review has shown that there has been an increase in the number of tuberculosis patients since 1980 .A large proportion of …

    zimbabwe Repository record for Outcome of Tuberculosis treatment in sputum positive patients after eight months of anti-tuberculosis therapy (opens in a new tab)

  13. Outcome of Tuberculosis treatment in sputum positive patients after eight months of anti-tuberculosis therapy

    … of the study was to find out the outcome of tuberculosis treatment in Sputum Positive Patients after eight months anti-tuberculosis treatment. Observation and literature review has shown that there has been an increase in the number of tuberculosis patients since 1980 .A large proportion of …

    zambia Repository record for Outcome of Tuberculosis treatment in sputum positive patients after eight months of anti-tuberculosis therapy (opens in a new tab)

  14. Optimal tuberculosis case-finding methodologies for field trials of new tuberculosis vaccines in young children

    … case-finding strategies in field trials of new tuberculosis vaccines conducted in young children. To investigate case-finding and case detection methods for tuberculosis in tuberculosis field trials conducted in young children.

    cape-town Repository record for Optimal tuberculosis case-finding methodologies for field trials of new tuberculosis vaccines in young children (opens in a new tab)

  15. Investigating permeation of anti-mycobacterial agents in Mycobacterium tuberculosis and M. tuberculosis-infected macrophages in vitro as a model for early stage tuberculosis drug discovery

    Tuberculosis (TB) is the leading cause of death due to a single infectious disease and remains a major threat to global public health. The increasing emergence of multi-drug resistance to current anti-TB drugs, exacerbated by the long treatment duration, highlights the need for new effective …

    cape-town Repository record for Investigating permeation of anti-mycobacterial agents in Mycobacterium tuberculosis and M. tuberculosis-infected macrophages in vitro as a model for early stage tuberculosis drug discovery (opens in a new tab)

  16. Isolation and characterisation of novel DNA aptamers against Mycobacterium tuberculosis biomarkers: new tools for tuberculosis diagnostics

    Tuberculosis is a curable disease with an average treatment success rate of 86 %. Despite this, there were an estimated 1.5 million deaths due to tuberculosis in 2013, most of which occurred in low and middle income countries. In order to overcome tuberculosis in developing countries innovation in …

    cape-town Repository record for Isolation and characterisation of novel DNA aptamers against Mycobacterium tuberculosis biomarkers: new tools for tuberculosis diagnostics (opens in a new tab)

Page 1 of 57